These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 1621914)

  • 1. [Fibrinogen metabolism in juvenile uterine bleeding].
    Iaroslavskiĭ VK; Chalenko IO; Chalenko VV
    Akush Ginekol (Mosk); 1992 Jan; (1):48-50. PubMed ID: 1621914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibrinogen/fibrin degradation products (FDP/fdp). Characterization, anticoagulant activity, and influence on laboratory assays.
    Arnesen H
    J Oslo City Hosp; 1977 Jun; 27(6):69-80. PubMed ID: 142131
    [No Abstract]   [Full Text] [Related]  

  • 3. Epidemic hemorrhagic fever. The mechanism of coagulation and fibrinolysis.
    Xiang LB; Zhang ZY; Chen JM; Xiang JM; Cosgriff TM
    Chin Med J (Engl); 1990 May; 103(5):391-5. PubMed ID: 1975230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biological behavior of higher molecular weight products of fibrinolysis.
    Chang ML; Bang NU
    J Lab Clin Med; 1977 Jul; 90(1):216-26. PubMed ID: 874368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Fibrinogen degradation products, soluble fibrin and antithrombin III in toxic goiter patients].
    Panchenko VM; Salakhidinov Z; Khaĭkina MB
    Probl Endokrinol (Mosk); 1979; 25(1):11-5. PubMed ID: 581702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The coagulation and fibrinolysis systems and atherosclerosis.
    Tanaka K; Sueishi K
    Lab Invest; 1993 Jul; 69(1):5-18. PubMed ID: 8331898
    [No Abstract]   [Full Text] [Related]  

  • 7. [Kinetic alterations of coagulation-anticoagulation and the fibrinolytic system in patients with epidemic hemorrhagic fever and their significance].
    Dong CR
    Zhonghua Yi Xue Za Zhi; 1988 Dec; 68(12):678-81, 46. PubMed ID: 2907863
    [No Abstract]   [Full Text] [Related]  

  • 8. Fibrinolytic activity in patients with acute tonsillitis.
    Kosugi T; Hamaya M; Matsuo O; Mihara H
    Ann Otol Rhinol Laryngol; 1979; 88(3 Pt 1):366-7. PubMed ID: 464529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relation of haemostatic, fibrinolytic, and rheological variables to the angiographic extent of peripheral arterial occlusive disease.
    Woodburn KR; Lowe GD; Rumley A; Love J; Pollock JG
    Int Angiol; 1995 Sep; 14(3):219-25. PubMed ID: 8919237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Blood coagulation and fibrinolysis in spontaneous delivery].
    Fuse Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1984 Apr; 36(4):497-502. PubMed ID: 6715932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The role of DL and DH degradation products in the reactions of the plasmin hydrolysis of fibrinogen and fibrin].
    Rozenfel'd MA; Leonova VB; Khavkina LS
    Izv Akad Nauk SSSR Biol; 1991; (3):334-42. PubMed ID: 1835465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coagulation and fibrinolysis disorder in muscular dystrophy.
    Saito T; Takenaka M; Miyai I; Yamamoto Y; Matsumura T; Nozaki S; Kang J
    Muscle Nerve; 2001 Mar; 24(3):399-402. PubMed ID: 11353426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical significance of a new fibrinogen/fibrin degradation products(FDP) test using plasma samples for the diagnosis of fibrinogenolysis and fibrinolysis].
    Imoto K; Yasumuro Y; Taki M; Suzuki N; Tanabe H; Ichikawa Y
    Rinsho Byori; 2001 Mar; 49(3):283-9. PubMed ID: 11307330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma fibrinogen, fibrinolytic activity and serum fibrinogen/fibrin degradation products in ischaemic heart disease.
    Dube B; Somani PN; Tripathi GK; Dube RK; Bhattacharya SK
    J Assoc Physicians India; 1985 Dec; 33(12):784-5, 787. PubMed ID: 3837002
    [No Abstract]   [Full Text] [Related]  

  • 15. Evidence that fibrin(ogen) degradation products (FDP) are adequately quantified in citrated plasma defibrinated at low pH.
    Godal HC; Hamborg T
    Scand J Haematol; 1984 Jan; 32(1):46-8. PubMed ID: 6695150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Differentiation of fibrinolysis and fibrinogenolysis by analysis of FDP fragments].
    Okumura N; Furuwatari C; Ishikawa S; Furihata K; Katsuyama T; Kanai M; Nakahata T; Saitoh H
    Rinsho Byori; 1992 Jul; 40(7):789-94. PubMed ID: 1507499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Significance of the laboratory diagnosis of hypercoagulability].
    Vorlová Z; Dyr JE
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(4):450-5. PubMed ID: 6083910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Problems of diagnosis of disseminated intravascular coagulation (DIC).
    Bowie EJ; Owen CA
    Southeast Asian J Trop Med Public Health; 1979 Sep; 10(3):325-7. PubMed ID: 515796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibrin degradation products. A review of structures found in vitro and in vivo.
    Gaffney PJ
    Ann N Y Acad Sci; 2001; 936():594-610. PubMed ID: 11460518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Nonenzymatic fibrinolysis].
    Dzhurdzhev A; Atanasov K
    Vutr Boles; 1981; 20(3):18-22. PubMed ID: 6455858
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.